Feedback / Questions
Bunavail (buprenorphine/naloxone transmucosal) - BDSI
Bunavail- Market exclusivity expiry
(Orange Book)
-
Jun 7, 2017 -
Market exclusivity expiry date listed in Orange Book as Jun 6, 2017
Commercial
•
Addiction (Opioid and Alcohol) • CNS Disorders
https://www.accessdata.fda.gov/scripts/cder/ob/search_patent.cfm?listed=new
Jun 7, 2017
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious